Author: Inchingolo, Alessio Danilo; Inchingolo, Angelo Michele; Bordea, Ioana Roxana; Malcangi, Giuseppina; Xhajanka, Edit; Scarano, Antonio; Lorusso, Felice; Farronato, Marco; Tartaglia, Gianluca Martino; Isacco, Ciro Gargiulo; Marinelli, Grazia; D’Oria, Maria Teresa; Hazballa, Denisa; Santacroce, Luigi; Ballini, Andrea; Contaldo, Maria; Inchingolo, Francesco; Dipalma, Gianna
Title: SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention Cord-id: ag2dlp8c Document date: 2021_3_4
ID: ag2dlp8c
Snippet: The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a high-risk viral agent involved in the recent pandemic stated worldwide by the World Health Organization. The infection is correlated to a severe systemic and respiratory disease in many cases, which is clinically treated with a multi-drug pharmacological approach. The purpose of this investigation was to evaluate through a literature overview the effect of adjuvant therapies and supplements for the SARS-CoV-2 infection. The re
Document: The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a high-risk viral agent involved in the recent pandemic stated worldwide by the World Health Organization. The infection is correlated to a severe systemic and respiratory disease in many cases, which is clinically treated with a multi-drug pharmacological approach. The purpose of this investigation was to evaluate through a literature overview the effect of adjuvant therapies and supplements for the SARS-CoV-2 infection. The research has analyzed the advantage of the EK1C4, by also assessing the studies on the resveratrol, vitamin D, and melatonin as adjuvant supplements for long hauler patients’ prognosis. The evaluated substances reported important benefits for the improvement of the immune system and as a potential inhibitor molecules against SARS-CoV-2, highlighting the use of sartans as therapy. The adjuvant supplements seem to create an advantage for the healing of the long hauler patients affected by chronic symptoms of constant chest and heart pain, intestinal disorders, headache, difficulty concentrating, memory loss, and tachycardia.
Search related documents:
Co phrase search for related documents- access site and acute respiratory infection: 1, 2
- action mechanism and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- action mechanism and acute inflammatory syndrome: 1, 2, 3, 4, 5
- action mechanism and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- action mechanism and acute respiratory distress syndrome ards: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- action mechanism and acute respiratory infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- active compound and acute ards respiratory distress syndrome: 1, 2
- active compound and acute respiratory distress syndrome: 1, 2
- active compound and acute respiratory distress syndrome ards: 1, 2
- active compound and acute respiratory infection: 1
- active fungal infection and acute respiratory infection: 1
- active ingredient and acute ards respiratory distress syndrome: 1
- active ingredient and acute respiratory distress syndrome: 1
- active ingredient and acute respiratory distress syndrome ards: 1
- active ingredient and acute respiratory infection: 1, 2
- active tuberculosis and acute respiratory distress syndrome: 1, 2, 3
- active tuberculosis and acute respiratory distress syndrome ards: 1
- active tuberculosis and acute respiratory infection: 1
Co phrase search for related documents, hyperlinks ordered by date